B. Küfferle

发表

EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms Comparative studies with remoxipride/haloperidol

P. Anderer, B. Saletu, J. Grünberger, 1990, European Neuropsychopharmacology.

A double‐blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia

D. Stein, B. Gallhofer, B. Küfferle, 1990, Acta psychiatrica Scandinavica. Supplementum.

Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.

S. Kasper, B. Küfferle, Siegfried Kasper, 1998, Journal of clinical psychopharmacology.

Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance

S. Kasper, L. Pezawas, B. Küfferle, 2000, International clinical psychopharmacology.

Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Psychopharmacology.

British Phenomenological and Psychopathological Concepts: A Comparative Review

B. Küfferle, P. Berner, 1982, British Journal of Psychiatry.

Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

S. Kasper, L. Pezawas, B. Küfferle, 1999, European Archives of Psychiatry and Clinical Neuroscience.

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Psychopharmacology.

63-2 Sertindole and dopamine D2 receptor occupancy

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Biological Psychiatry.

P.2.069 123I IBZM spect imaging of dopamine-2 receptors in psychotic patients treated with zotepine

S. Kasper, B. Küfferle, S. Asenbaum, 1997, European Neuropsychopharmacology.

P-4-32 IBZM-SPECT and D2 dopamine receptor occupancy: Different profiles with atypical neuroleptics

S. Kasper, B. Küfferle, S. Asenbaum, 1995, European Neuropsychopharmacology.

Occurrence of mirtazapine-induced delirium in organic brain disorder — Three case reports

S. Kasper, B. Küfferle, U. Bailer, 2000, European Neuropsychopharmacology.

Course and outcome of delusional psychoses.

R. Trappl, B. Küfferle, H. Schanda, 1984, Psychopathology.

Predicting course and outcome in delusional psychoses

B. Küfferle, H. Schanda, P. Berner, 1991, Acta psychiatrica Scandinavica.

Occurrence of mirtazapine-induced delirium in organic brain disorder.

S. Kasper, B. Küfferle, U. Bailer, 2000 .

Neurophysiological Aspects of Positive and Negative Schizophrenia and Therapeutic Consequences: Trials with Benzamides

P. Anderer, B. Saletu, J. Grünberger, 1998 .

Are There Plus and Minus Symptoms “Specific” for Schizophrenia?

B. Küfferle, H. Schanda, P. Berner, 1985 .

The genetics of delusional psychoses.

B. Küfferle, H. Schanda, P. Berner, 1983, Schizophrenia bulletin.

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

S. Kasper, B. Küfferle, S. Asenbaum, 2002, Psychopharmacology.

Antipsychotic Efficacy of Fluperlapine

E. Rüther, M. Koukkou, B. Küfferle, 1984 .

Quantitative EEG, SPEM, and Psychometric Studies in Schizophrenics before and during Differential Neuroleptic Therapy

P. Anderer, B. Saletu, J. Grünberger, 1986, Pharmacopsychiatry.

Letter: Reversal by physostigmine of clozapine-induced delirium.

P. Schuster, B. Küfferle, E. Gabriel, 1976, Lancet.

Receptor and Transporter Imaging Studies in Schizophrenia, Depression, Bulimia and Tourette's Disorder—Implications for Psychopharmacology-

Ivo Podreka, Alexander Neumeister, Siegfried Kasper, 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.

Bernd Saletu, Peter Anderer, Josef Grünberger, 1994 .

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

L. Deecke, B. Küfferle, P. Angelberger, 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Smooth pursuit eye movements in schizophrenia: influences of neuroleptic treatment and the question of specificity.

P. Anderer, B. Küfferle, K. Steinberger, 1990, Psychopathology.

Clinical evaluation of language and thought disorders in patients with schizophrenic and affective psychoses.

B. Küfferle, H. Schanda, G. Lenz, 1985, Psychopathology.

Extrapyramidal symptoms with atypical antipsychotics: A [123i]IBZM SPECT study

B. Küfferle, S. Asenbaum, J. Tauscher, 2002, European Neuropsychopharmacology.

Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol – a 123I-IBZM SPECT study

S. Kasper, B. Küfferle, S. Asenbaum, 1998, Psychopharmacology.

Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone

S. Kasper, B. Küfferle, S. Asenbaum, 1996, Psychiatry Research: Neuroimaging.

In vivo 123I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients

S. Kasper, B. Küfferle, M. Willeit, 2001, Psychopharmacology.

In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

P. Fischer, S. Kasper, L. Pezawas, 1999, Psychopharmacology.

Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression

S. Kasper, B. Küfferle, P. Fischer, 1998, International clinical psychopharmacology.

Clinically Relevant Differences in the Therapeutic Profile of Fluperlapine Compared to Haloperidol in the Treatment of Schizophrenic Psychosis - Results of a Multicentre Double-blind Study

E. Rüther, B. Küfferle, H. Beckmann, 1986 .

Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.

E. Rüther, B. Küfferle, B. Müller-Oerlinghausen, 1984, Arzneimittel-Forschung.

Occurrence of trazodone‐induced delirium

B. Küfferle, C. Lennkh, Peter Fischer, 1998, International clinical psychopharmacology.

Computer-assisted EEG topography as a tool in the evaluation of actions of psychoactive drugs in patients.

H. Petsche, P. Rappelsberger, B. Küfferle, 1984, Neuropsychobiology.

Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine.

B. Küfferle, T. Brücke, Christine Vesely, 2000, International clinical psychopharmacology.